Sarns Soft-Flow Aortic Cannulae 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Terumo Cardiovascular Systems Corporation 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2012-12-24
  • 사례 출판 날짜
    2012-12-24
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: terumo sarns soft-flow aortic cannulae medical device manufacturer, terumo cardiovascular systems corporation, has issued a medical device safety alert concerning sarns soft-flow aortic cannulae. affected catalogue numbers are 5762, 5768, 5774, 5841, 5843, 5845, 5847, 7071, 7072. during in-house inspection, terumo cardiovascular systems (terumo cvs) identified the presence of excess plastic material, or flash, on the tip of the sarns soft-flow aortic cannula. the flash has the potential to detach. terumo cvs’ investigation revealed that: the flash occurred during the molding process of the cannula tip. other product lots may exhibit the same issue. the mold was corrected to resolve the observed condition. terumo cvs is advising users to discontinue use and return all affected cannulae in inventory. it is because the presence of plastic flash on the cannula tip may or may not be visually detected by users. if plastic flash material is present, there is the potential for it to become dislodged and deposited in the patient’s vascular system resulting in varying degrees of patient harm, depending on the size of the dislodged material, the location in which it is deposited, and the condition of the patient. potential outcomes include inflammatory response which can create clot, ischemia, or tissue death. according to the local supplier, the affected products have not been distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 24 december 2012.

Device

Manufacturer